Foreign investors have the same shareholding cap as domestic investors in insurance asset management companies. CSRC sets forth disclosure requirements for listed pharma companies. Land approval procedures for infrastructure projects are streamlined.
Nate Bush and Della Ding of DLA Piper and Ray Xu of Shanghai Kaiman Law Firm assess the implications for dominant firms of recent amendments to China's key anti-monopoly legislation and proposed revisions to its implementing rules.
Research casts doubt on US-listed Chinese companies' ability to list in Hong Kong; Grocery delivery company in legal trouble following collapse; new rules on convertible bonds
CBIRC allows multinationals to set up their own group finance companies and enriches the life insurance disclosure requirements of insurance companies. CNIPA enhances IP protection of exhibitions.
Nate Bush and Della Ding of DLA Piper and Ray Xu of Shanghai Kaiman Law Firm review new regulations prohibiting monopoly agreements, abuse of intellectual property rights and as actions that eliminate or restrict competition, as well as discussing the potential penalties for violations.
The U.S. adds Alibaba to delisting list, citing audit non-compliance; Integration of Shenzhen and Swiss bourses; Six ESG-linked indices launched in Shenzhen